Search
Saturday 15 August 2015
  • :
  • :

Pre-Market News Analysis on: Realty Income (NYSE:O), Prima Biomed Ltd Prima Biomed (NASDAQ:PBMD), (Aberdeen Asia-Pacific Income Fund (NYSEMKT:FAX), Golar LNG (NASDAQ:GLNG)

On Monday, Realty Income Corp (NYSE:O)’s shares inclined 0.43% to $47.19.

Realty Income Corporation ( O), The Monthly Dividend Company®, declared that its Board of Directors has declared the 541st successive common stock monthly dividend. The dividend amount of $0.19 per share, representing an annualized amount of $2.28 per share, is payable on August 17, 2015 to shareholders of record as of August 3, 2015.

The Board of Directors also declared dividends on the company’s Monthly Income Class F preferred stock. The monthly dividend amount of $0.138021 on the Class F preferred shares is payable on August 17, 2015 to shareholders of record as of August 1, 2015. The annualized dividend amount for the Class F preferred shares is $1.65625 per share.

Realty Income Corporation is a publicly traded real estate investment trust. It invests in the real estate markets of the United States. The firm makes investments in commercial real estate. Realty Income Corporation was founded in 1969 and is based in Escondido, California.

Prima Biomed Ltd. (NASDAQ:PBMD)’s shares dropped -5.92% to $1.35.

Prima BioMed Ltd (PBMD) a leading immuno-oncology company, is happy to declare that it has received positive Scientific Advice from the European Medicines Agency (“EMA” or the “Agency”) on the development path for its lead product, IMP321 in metastatic breast cancer.

The EMA, located in London, is the agency responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. After dialogue between Prima and the EMA, the Agency has now confirmed in writing its endorsement of the development program of IMP321 in metastatic breast cancer.

Prima BioMed Ltd. researches, develops, and commercializes medical biotechnology products in Australia. The company develops immunocellular therapeutic products for the treatment of cancer. Its lead product is CVac, an autologous dendritic cell-based product presently in clinical trials for ovarian and pancreatic cancer patients. Prima BioMed Ltd. is based in Sydney, Australia.

At the end of Monday’s trade, Aberdeen Asia-Pacific Income Fund, Inc. (NYSEMKT:FAX)‘s shares dipped -0.62% to $4.78.

Aberdeen Asia-Pacific Income Fund, Inc. (FAX) a closed-end fund, declared that it will pay on July 28, 2015, a distribution of US $0.035 per share to all shareholders of record as of July 21, 2015.

Under U.S. tax rules applicable to the Fund, the amount and character of distributable income for each fiscal year can be finally determined only as of the end of the Fund’s fiscal year. However, under Section 19 of the Investment Company Act of 1940, as amended (the “1940 Act”) and related Rules, the Fund may be required to indicate to shareholders the source of certain distributions to shareholders.

Aberdeen Asia-Pacific Income Fund, Inc. (the Fund) is a closed-end, non-diversified administration investment company. The Fund’s investment objective is to seek current income. It may also achieve incidental capital appreciation. The Fund normally invests at least 80% of its net assets plus the amount of any borrowings for investment purposes in Asian debt securities, Australian debt securities and New Zealand debt securities. Asian Countries comprise Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Pakistan, the Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam, Sri Lanka, Kazakhstan and Mongolia, and such other countries on the Asian continent approved for investment by the investment manager of the Fund. Aberdeen Asset Administration Asia Limited serves as investment manager to the Fund.

Golar LNG Limited (USA) (NASDAQ:GLNG), ended its Monday’s trading session with -1.50% loss, and closed at $41.33.

Golar LNG Limited advises that its 2015 Annual General Meeting will be held on September 23, 2015. The record date for voting at the Annual General Meeting is set to July 28, 2015. The notice, agenda and associated material will be distributed prior to the meeting.

Golar LNG Limited, a midstream liquefied natural gas (LNG) company, engages in the transportation, regasification, liquefaction, and trading of LNG. The company operates in three segments: Vessel Operations, LNG Trading, and FLNG. It is involved in the acquisition, ownership, operation, and chartering of LNG carriers and floating storage regasification units (FSRUs); and the development of LNG projects.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *